证券代码：002258 股票简称：利尔化学 公告编号：2025-004 利尔化学股份有限公司 第六届董事会第二十次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确 和完整，没有虚假记载、误导性陈述或重大遗漏。 2025 年 3 月 26 日，利尔化学股份有限公司（以下简称"公司"或 "利 尔化学"）第六届董事会第二十次会议在四川成都公司会议室以现场方 式召开，会议通知及资料于 2025 年 3 月 16 日以电子邮件方式送达。 应出席会议的董事 9 人，实际出席会议的董事 9 人，公司监事及部分高 管列席了会议。会议程序符合《公司法》和公司章程的规定。会议由公 司董事长尹英遂主持，经过与会董事认真审议，形成如下决议： 一、会议以 9 票同意，0 票弃权，0 票反对的结果，审议通过了《公 司 2024 年度总经理工作报告》。 四、会议以 9 票同意，0 票弃权，0 票反对的结果，审议通过了 《公司 2024 年度董事会工作报告》。 《公司 2024 年度董事会工作报告》的详细内容刊登于 2025 年 3 月 28 日的巨潮资讯网。 公司独立董事向董事会提交了《独立董事 2024 年度述职报告》， ...

证券代码：002258 股票简称：利尔化学 公告编号：2025-010 利尔化学股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证信息披露内容的真实、准确 和完整，没有虚假记载、误导性陈述或重大遗漏。 2025 年 3 月 26 日，利尔化学股份有限公司（以下简称"公司"） 第六届董事会第二十次会议以 9 票同意、0 票反对、0 票弃权的表决结 果通过了《关于 2024 年度利润分配的议案》，公司第六届监事会第十二 次会议以 3 票同意、0 票反对、0 票弃权的表决结果通过了《关于 2024 年度利润分配的议案》。该项议案尚需提交公司 2024 年年度股东会审 议。现将相关事宜公告如下： 一、利润分配预案的基本情况 经中汇会计师事务所（特殊普通合伙）审计，2024 年度实现归属于 上市公司股东的净利润 215,336,804.61 元，其中：母公司实现净利润 104,614,202.51 元 ， 按 公 司 《 章 程 》 规 定 提 取 法 定 盈 余 公 积 10,461,420.25 元，加：年初未分配利润 2,336,355,325.50 元，公司期 末实际可供股东分配的 ...

Financial Performance - The company's operating revenue for 2024 was ¥7,310,881,683.09, a decrease of 6.87% compared to ¥7,850,607,495.62 in 2023[22] - The net profit attributable to shareholders for 2024 was ¥215,336,804.61, down 64.34% from ¥603,888,241.89 in 2023[22] - The net cash flow from operating activities decreased by 66.70% to ¥312,504,412.62 in 2024 from ¥938,573,493.36 in 2023[22] - Basic earnings per share for 2024 were ¥0.2690, a decline of 64.34% compared to ¥0.7544 in 2023[22] - The total assets at the end of 2024 increased by 5.53% to ¥15,648,477,597.25 from ¥14,828,962,478.88 at the end of 2023[22] - The net assets attributable to shareholders rose by 3.12% to ¥7,726,587,850.26 at the end of 2024 compared to ¥7,492,542,596.34 at the end of 2023[22] - The weighted average return on equity for 2024 was 2.83%, down from 8.30% in 2023, reflecting a decrease of 5.47%[22] - The company reported a significant decline in net profit and cash flow, indicating potential challenges in maintaining operational efficiency and profitability moving forward[22] Dividend and Shareholder Returns - The company plans to distribute a cash dividend of ¥2 per 10 shares to all shareholders, based on a total of 800,437,228 shares[5] - The total distributable profit for the year is 2,430,508,107.76 CNY, with cash dividends accounting for 100% of the profit distribution[158] - The company has not proposed a cash dividend distribution plan despite achieving a positive distributable profit, which requires disclosure of reasons and future plans to enhance investor returns[157] Market and Industry Trends - The global pesticide market size grew from $35.575 billion in 2006 to $87.7 billion in 2022, with a compound annual growth rate of approximately 5.80%[29] - The domestic pesticide market is currently facing an oversupply situation, leading to intensified competition and price stabilization[32] - The global market for Glufosinate is expected to grow significantly due to the increasing adoption of transgenic crops and the decline in prices of Glufosinate[36] - The company is positioned to benefit from the ongoing transformation towards green and efficient agricultural practices as outlined in the recent government policies[33] Research and Development - The company has a robust R&D framework with multiple patents, ensuring the stability of its product efficacy and safety[44] - The company is actively pursuing new product development and market expansion strategies[49] - The company plans to continue increasing R&D investment, establishing a Shanghai R&D center and enhancing collaboration with the Chengdu center to improve product development efficiency[103] - Research and development expenses amounted to RMB 264,204,717.45, a decrease of 12.48% compared to the previous year[75] Environmental Compliance and Sustainability - The company adheres to various environmental protection laws and regulations, ensuring compliance in its operations[169] - The company has established comprehensive "three wastes" treatment facilities in accordance with various national and local environmental standards, aiming to minimize negative ecological impacts[170] - The company has implemented a 2024 environmental self-monitoring plan, with all monitoring data meeting national and local standards, and no exceedance of emission limits reported[185] - The company emphasizes energy efficiency and carbon reduction in new projects and existing product upgrades, adopting advanced production processes and energy-saving equipment[185] Corporate Governance - The company maintains complete independence from its controlling shareholder in terms of business, personnel, assets, organization, and finance[120] - The board of directors consists of 9 members, including 3 independent directors with expertise in capital operations and financial accounting[117] - The company has established a fair and transparent performance evaluation and incentive mechanism for its directors, supervisors, and management[118] - The company has a dedicated audit department with 4 full-time auditors to oversee internal controls and financial conditions[119] Employee Engagement and Welfare - The total number of employees at the end of the reporting period is 5,760, with 1,748 in the parent company and 4,012 in major subsidiaries[147] - The company provided over 330,000 RMB worth of summer cooling supplies to employees during the high-temperature season[191] - A total of 18 labor skill competitions were organized, with over 15,000 employee participants, enhancing safety awareness and skills[192] - The company assisted 50 employees in need with approximately 215,000 RMB in support funds throughout the year[193] Risk Management - The company faces various risks including market competition, environmental risks, and international trade friction, which investors should be aware of[5] - The company has established a risk warning mechanism to prevent operational risks and ensure stable development[164] - Environmental regulations will require increased investment in waste management and carbon reduction technologies, impacting profitability[104] Strategic Initiatives - The company is actively expanding its international sales channels, including establishing subsidiaries in Cambodia to enhance its global brand presence[41] - The company plans to enhance production efficiency by optimizing talent selection, training, and incentives, aiming for improved per capita productivity[101] - Significant investments will be made in key projects, including the completion and production launch of the Jingzhou base and the second phase of the Bide Biochemical project[101]

// 热点聚焦 // 1、国务院总理李强在北京出席中国发展高层论坛2025年年会开幕式并发表主旨演讲。李强表示， 将实施更加积极有为的宏观政策，进一步加大逆周期调 节力度，必要时推出新的增量政策，为经济持续向好、平稳运行提供有力支撑。 深化经济体制改革，不断推进全国统一大市场建设，着力打通经济循环 的堵点卡点，为各类经营主体进一步营造良好发展环境。 // 环球市场 // 1、未来一周，全球市场大事不断。 AH股密集发布财报，比亚迪、泡泡玛特等在列；多个经济体公布重要数据，美联储最关注通胀指标来袭；中国 央行1.4万亿逆回购到期； 博鳌亚洲论坛、中关村论坛相继开幕；苹果将于上海举行开发者活动，苹果智能中国版或推出。 // 宏观 // 1、国务院总理李强会见美国联邦参议员戴安斯一行。李强表示， 打贸易战没有赢家。没有哪个国家的发展繁荣是靠加征关税实现的，只能靠开放、靠合 作。我们应当通过做大合作蛋糕，用更多利益增量去解决贸易不平衡等问题。 中国始终欢迎包括美国在内的各国企业来华分享发展机遇，将积极推动解 决企业合理诉求，对内外资企业一视同仁。 2、国务院副总理何立峰会见跨国公司负责人时指出，中国经济韧性强、潜力大 ...

证券代码：002258 股票简称：利尔化学 公告编号：2025-003 利尔化学股份有限公司 关于筹划对外投资事项的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、利尔化学股份有限公司（以下简称"公司"）本次拟对外投资事 项目前尚未正式签署任何交易协议，尚处于筹划阶段，最终的投资金额 和股权比例尚未确定，具体的投资方案仍需进一步研究论证和沟通协商。 2、根据初步测算，本次拟对外投资事项预计不会达到《上市公司 重大资产重组管理办法》规定的重大资产重组条件，不构成重大资产重 组；本次对外投资事项亦不构成关联交易。 3、公司将根据本次拟投资事项的后续进展，在具体合作事宜明确 后，按照中国证监会、深圳证券交易所相关规定以及公司内部相关制度 及时履行相应决策程序和信息披露义务。 4、公司本次拟对外投资事项能否最终完成存在不确定性，请广大 投资者注意投资风险。 4、企业类型：股份有限公司（非上市、自然人投资或控股） 5、注册资本：10519.6667 万人民币 一、本次筹划事项概述 根据公司发展战略规划，为拓展产业链，进一步提升公司竞争力， 1 ...

Financial Performance - Total revenue for 2024 was 731,088.17 million, a decrease of 6.87% compared to the previous year[4] - Operating profit fell to 35,251.15 million, down 60.00% year-on-year[4] - Net profit attributable to shareholders decreased by 64.34% to 21,533.68 million[4] - Basic earnings per share dropped to 0.2690, a decline of 64.34% from 0.7544[4] - The performance results are consistent with the previously disclosed earnings forecast[7] Assets and Equity - Total assets increased by 5.53% to 1,564,847.76 million[5] - Shareholders' equity rose by 3.12% to 772,658.79 million[5] - The company’s net assets per share increased to 9.6530, up 3.12% from the previous period[5] Market Conditions - The company faced intense market competition, leading to a decline in sales prices[6] Internal Review - The internal audit department has reviewed the preliminary financial data[3]

Financial Performance Forecast - The company expects a net profit attributable to shareholders of 190 million yuan for 2024, a decrease of 68.54% compared to the previous year's profit of 600 million yuan [2]. - The net profit after deducting non-recurring gains and losses is projected to be 180 million yuan, down 69.85% from 600 million yuan in the same period last year [2]. - Basic earnings per share are estimated to be between 0.2374 yuan and 0.2748 yuan, compared to 0.7544 yuan per share in the previous year [2]. Market Competition - The company faces intense market competition for its core products, leading to a significant decline in sales prices despite an increase in production and sales volume [5]. Reporting and Data Disclosure - The performance forecast is based on preliminary calculations by the finance department, with detailed data to be disclosed in the 2024 annual report [6].

Group 1: Market Overview - The current pesticide market demand is stable, with inventory levels returning to normal after previous years [2] - Industry capacity has increased significantly compared to previous years, but market concentration has improved, with leading companies gradually expanding their market share [2] Group 2: Product Insights - The company is optimistic about the market potential for precision glyphosate, expecting continued growth in demand due to product registrations, market promotion, and production technology improvements [2][3] - The company is actively advancing the registration and market layout of precision glyphosate in multiple overseas countries [2][3] Group 3: Future Growth and Development Plans - The company plans to fully promote the precision glyphosate project and implement a series of new product sales according to its strategic plan [3] - Continuous technical improvements will be made to existing products to enhance competitiveness, alongside efforts to expand market demand and accelerate new product development [3] Group 4: External Factors and Strategic Responses - The company's raw material products are not included in the list of items subject to additional tariffs by the U.S. [3] - The company is preparing to explore new markets, accelerate new product development, and strengthen cooperation with peers in response to external challenges [3] Group 5: Corporate Governance and Management - The company is considering an incentive plan, but it is still under discussion and has not been finalized [3] - The company is attentive to the recent guidelines issued by the State-owned Assets Supervision and Administration Commission regarding market value management and will actively communicate with its controlling shareholders [3]

Market Trends and Product Development - The company is optimistic about the market potential of glufosinate-ammonium (精草铵膦) and expects market demand to continue growing [2] - The company is actively promoting the registration and market layout of glufosinate-ammonium in multiple overseas countries [2] - The 20,000 tons/year enzymatic glufosinate-ammonium project in Jinshi, Hunan has been put into production and is operating normally [2] - The company will focus on advancing the glufosinate-ammonium project and optimizing production technologies for new projects [2] Strategic Planning and Future Growth - The company plans to continue improving existing products through technological upgrades to reduce costs and enhance competitiveness [3] - Efforts will be made to strengthen marketing, expand market demand, and accelerate the development and commercialization of new products to increase revenue sources [3] - The company is actively following up on the non-public offering plan, which is currently awaiting approval from state-owned shareholders [3] - The company is studying the possibility of introducing an incentive plan but has not yet made a decision [3] Regulatory Compliance and Market Management - The company attaches great importance to the "Guidelines for Listed Company Supervision No. 10 - Market Value Management" issued by the China Securities Regulatory Commission and is actively studying and researching it [3]

Investment Rating - The report maintains an "Accumulate" rating for the company [4]. Core Views - The company's performance in Q3 2024 was under pressure due to a significant decline in the price of glyphosate, which has dropped to historical lows [2][4]. - The company is actively advancing the construction of its refined glyphosate production capacity, with several projects underway [3][4]. Summary by Sections Financial Performance - For the first three quarters of 2024, the company achieved revenue of 5.188 billion yuan, a year-on-year decrease of 13.62%, and a net profit attributable to shareholders of 132 million yuan, down 76.44% year-on-year [1]. - In Q3 2024, the company reported revenue of 1.859 billion yuan, an increase of 20.91% year-on-year but a decrease of 4.13% quarter-on-quarter; the net profit attributable to shareholders was 39 million yuan, down 51.42% year-on-year and 13.47% quarter-on-quarter [1][2]. Market Conditions - The average market price of glyphosate in China was 56,000 yuan per ton in 2023, a year-on-year decline of 36.5%, and it further decreased to 50,000 yuan per ton by November 4, 2024, down 28.6% from the beginning of the year [2]. - The company's gross margin for the first three quarters of 2024 was 16.3%, a decrease of 8.6 percentage points year-on-year [2]. Production Capacity and Strategy - The company operates seven production bases and is the largest producer of chlorinated pyridine pesticides and glyphosate in China [3]. - As of June 2024, the company's subsidiary had a refined glyphosate project with an annual capacity of 20,000 tons that was operating normally, while another project with a capacity of 10,000 tons was still under construction [3]. - The company has initiated registration and market layout for refined glyphosate in multiple countries, completing registration in five countries [3]. Profit Forecast and Valuation - Due to the continued low prices of glyphosate, the profit forecasts for 2024-2026 have been revised downwards, with expected net profits of 190 million yuan (down 74.0%), 324 million yuan (down 60.5%), and 437 million yuan (down 53.8%) respectively [4].